`

Fermelanta, Inc

Biotechnology Research

Specialities :
Synthetic biology
Metabolic engineering
Genetic engineering
Chemical engineering
Applied microbiology

+1

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$1.4M
size-icon Size
11 - 50

Frequently Asked Questions About Fermelanta, Inc

What does Fermelanta, inc do?+

Fermelanta is a Japan-based biotech company that makes beneficial plant-based chemicals by microorganisms. We transform the traditional supply chain depending on agricultural cultivation and extraction into a next-gen microbial fermentation process that can offer low-cost and high-quality products timely. Our cutting-edge technology is introduction and expression techniques and knowhow of unprecedented foreign genes in a cell factory to make microorganisms produce extrinsic metabolites for industrial usage. The target natural molecules are used for health food, cosmetics or approved drugs. Founded in October 2022, we are currently in a lab-based R&D stage and under the first-financing seed round

What are Fermelanta, inc's specialties? +

Synthetic biology,metabolic engineering,genetic engineering,chemical engineering,applied microbiology,and molecular biology

What is Fermelanta, inc's industry? +

Fermelanta, inc operates in the Biotechnology research industry.

What is Fermelanta, inc's revenue? +

Fermelanta, inc's revenue is 11m - 100m

What is Fermelanta, inc's company size? +

Fermelanta, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.